Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Vascular Solutions (VASC) '3-for-3' in 2015; Canaccord Genuity Reiterates Buy
October 21, 2015 11:07 AM EDTCanaccord Genuity reiterated a Buy rating and $41.50 price target on Vascular Solutions (NASDAQ: VASC), following the company's 3Q15 earnings results. VASC reported its 3rd straight quarter beat and raise in 2015, beating consensus' EPS by $0.02.
Analyst Jason Mills commented, "In terms of a beat and raise batting average,... More
